Kyntra Bio, Inc. (KYNB)
7.39
+0.31
(+4.38%)
USD |
NASDAQ |
Apr 14, 16:00
7.39
0.00 (0.00%)
After-Hours: 20:00
Kyntra Bio Total Liabilities (Quarterly) : 115.12M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anixa Biosciences, Inc. | 1.387M |
| GT Biopharma, Inc. | 2.319M |
| Gossamer Bio, Inc. | 295.01M |
| Monte Rosa Therapeutics, Inc. | 215.60M |
| Septerna, Inc. | 220.06M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 119.59M |
| Shareholders Equity (Quarterly) | -30.04M |
| Debt to Equity Ratio | -0.6512 |
| Current Ratio | 3.388 |
| Net Debt Paydown Yield | 41.38% |